GlassScriptPhysician profile
Anita Thompkins
NPI 1619324829
$4,894.13
in general payments reported to CMS, 2019-2025
23 companies · $1,023 in 2025
The $1,023 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $448 · 2022: $850 · 2023: $907 · 2024: $1,666 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,959 · Travel and Lodging: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.41 |
| Travel and Lodging | $636.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,499.36 | 2022-2025 | Symplicity G3, Avalus |
| Abbott Laboratories | $467.84 | 2021-2025 | Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.74 | 2021-2025 | Jardiance |
| Biotronik INC. | $354.66 | 2022-2025 | Biomonitor, Acticor 7 Vr-T Dx, Selectra |
| Janssen Pharmaceuticals, INC | $312.69 | 2022-2024 | Xarelto |
| Amgen INC. | $243.51 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $231.87 | 2022-2024 | Andexxa, Brilinta |
| Actelion Pharmaceuticals US, INC. | $201.84 | 2022-2023 | Uptravi, Opsumit |
| Edwards Lifesciences Corporation | $155.88 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $141.00 | 2025 | Camzyos |
| Pfizer INC. | $128.39 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $125.67 | 2023-2025 | Verquvo, Capvaxive |
| Scpharmaceuticals INC. | $121.86 | 2025 | |
| Novartis Pharmaceuticals Corporation | $111.52 | 2023-2025 | |
| Boston Scientific Corporation | $86.89 | 2022-2023 | Bodyguardian, Watchman Flx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $58.86 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.46 | 2023-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $39.15 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $38.32 | 2025 | Assure Wcd |
| Esperion Therapeutics, INC. | $32.51 | 2022 | |
| Inari Medical, INC. | $29.96 | 2022 | |
| Baxter Healthcare | $29.87 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Cvrx, INC. | $17.28 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Thompkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.